Yidi Zhu

发表

Modified FOLFIRINOX versus gemcitabine plus oxaliplatin as first-line chemotherapy for patients with locally advanced or metastatic cholangiocarcinoma: a retrospective comparative study

Xu’an Wang, Maolan Li, Xiangsong Wu, 2021, BMC cancer.

Word of Mouth Marketing in Education and Training Industry : A case study of Word of Mouth communication and its influence on consumer decision making process in the Chinese Education Market

Weili Gong, Yidi Zhu, Qianqian Wei, 2012 .

Successful conversion surgery for locally advanced gallbladder cancer after gemcitabine and nab-paclitaxel chemotherapy

Xiangsong Wu, Yichen Xiong, Xue-feng Wang, 2022, Frontiers in Oncology.

NOP2/Sun RNA methyltransferase 2 promotes tumor progression via its interacting partner RPL6 in gallbladder carcinoma

Zheng Wang, Ying-bin Liu, Fei Zhang, 2019, Cancer science.

Genomic ERBB2/ERBB3 mutations promote PD-L1-mediated immune escape in gallbladder cancer: a whole-exome sequencing analysis

Xiyong Liu, Maolan Li, Yijian Zhang, 2018, Gut.

Modified FOLFIRINOX for unresectable locally advanced or metastatic gallbladder cancer, a comparison with GEMOX regimen.

Maolan Li, Wen-guang Wu, Ying-bin Liu, 2021, Hepatobiliary surgery and nutrition.

LncRNA MNX1-AS1 sustains inactivation of Hippo pathway through a positive feedback loop with USP16/IGF2BP3 axis in gallbladder cancer.

Maolan Li, Xiangsong Wu, Huai-feng Li, 2022, Cancer letters.

Long noncoding RNA lncGALM increases risk of liver metastasis in gallbladder cancer through facilitating N‐cadherin and IL‐1β‐dependent liver arrest and tumor extravasation

Xiangsong Wu, Yijian Zhang, Ying-bin Liu, 2020, Clinical and translational medicine.

DNA methylation of RUNX3 promotes the progression of gallbladder cancer through repressing SLC7A11-mediated ferroptosis.

Xiangsong Wu, J. Mu, Yuan-yuan Ye, 2023, Cellular signalling.